rs761399728
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong
The NM_016194.4(GNB5):c.368C>T(p.Ser123Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,611,272 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S123W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_016194.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNB5 | NM_016194.4 | c.368C>T | p.Ser123Leu | missense_variant | 4/13 | ENST00000261837.12 | NP_057278.2 | |
GNB5 | NM_006578.4 | c.242C>T | p.Ser81Leu | missense_variant | 2/11 | NP_006569.1 | ||
GNB5 | NM_001379343.1 | c.86C>T | p.Ser29Leu | missense_variant | 2/11 | NP_001366272.1 | ||
GNB5 | XM_011521162.4 | c.242C>T | p.Ser81Leu | missense_variant | 2/11 | XP_011519464.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNB5 | ENST00000261837.12 | c.368C>T | p.Ser123Leu | missense_variant | 4/13 | 5 | NM_016194.4 | ENSP00000261837 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000558 AC: 14AN: 250808Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135554
GnomAD4 exome AF: 0.0000206 AC: 30AN: 1459082Hom.: 0 Cov.: 31 AF XY: 0.0000248 AC XY: 18AN XY: 725756
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74356
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 12, 2023 | Published functional studies demonstrate a damaging effect as p.(S123L) results in severe but incomplete loss of function, with lower expression levels and significantly impaired activity (Shamseldin et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27523599, 27677260, 31208990, 32552793, 31589614, 33176815, 30631341, 32280589, 31130284) - |
Pathogenic, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Gnb5-related intellectual disability-cardiac arrhythmia syndrome Pathogenic:2Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Jan 01, 2019 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2021 | The c.368C>T (p.S123L) alteration is located in exon 4 (coding exon 3) of the GNB5 gene. This alteration results from a C to T substitution at nucleotide position 368, causing the serine (S) at amino acid position 123 to be replaced by a leucine (L). Based on data from gnomAD, the T allele has an overall frequency of 0.01% (15/282212) total alleles studied. The highest observed frequency was 0.03% (11/35244) of Latino alleles. This mutation has been reported in the homozygous and compound heterozygous state in several individuals with GNB5-related neurodevelopmental disorder (Lin, 2020; Lodder, 2016; Monies, 2019; Shamseldin, 2016). Functional studies show that this alteration severely impacts dopamine responses (Shamseldin, 2016). The in silico prediction for this alteration is inconclusive. Based on the available evidence, this alteration is classified as pathogenic. - |
Delayed speech and language development;C0557874:Global developmental delay;C1263846:Attention deficit hyperactivity disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Feb 02, 2016 | - - |
Language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 16, 2023 | - - |
Language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia;C5568877:Gnb5-related intellectual disability-cardiac arrhythmia syndrome Other:1
not provided, no classification provided | phenotyping only | GenomeConnect, ClinGen | - | GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at